Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free OCSAW Stock Alerts

Oculis (OCSAW) Competitors

$4.22 -0.18 (-4.09%)
As of 06/5/2026 03:54 PM Eastern
Compare

OCSAW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Oculis stock or one of its competitors? MarketBeat compares Oculis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oculis include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Oculis compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Oculis. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Oculis. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
Oculis Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Oculis N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Oculis on 2 of the 2 factors compared between the two stocks.

How does Oculis compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Oculis N/A N/A N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
Alpha Tau Medical Neutral
Oculis Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

Summary

Alpha Tau Medical and Oculis tied by winning 0 of the 0 factors compared between the two stocks.

How does Oculis compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Oculis Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Oculis N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

Summary

Apollomics beats Oculis on 1 of the 1 factors compared between the two stocks.

How does Oculis compare to BioVie?

BioVie (NASDAQ:BIVIW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

In the previous week, BioVie's average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Oculis Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Oculis N/A N/A N/A

Summary

BioVie and Oculis tied by winning 0 of the 0 factors compared between the two stocks.

How does Oculis compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
OculisN/AN/AN/AN/AN/A

In the previous week, Cardio Diagnostics' average media sentiment score of 0.00 equaled Oculis'average media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Oculis Neutral

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Oculis N/A N/A N/A

Summary

Cardio Diagnostics beats Oculis on 1 of the 1 factors compared between the two stocks.

Get Oculis News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCSAW vs. The Competition

Export
MetricOculisBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$460.38M$6.68B$11.99B
Dividend YieldN/A3.87%2.67%5.55%
P/E RatioN/A3.1520.2921.86
Price / SalesN/A6,606.57519.33112.45
Price / CashN/A13.1342.2354.60
Price / BookN/A83.479.736.35
Net IncomeN/A-$96.07M$3.57B$337.59M
7 Day Performance-65.64%-1.89%-1.26%-2.51%
1 Month Performance-77.05%1.04%0.82%-0.69%
1 Year Performance-50.67%64.50%24.09%25.37%

Oculis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCSAW
Oculis
N/A$4.22
-4.1%		N/A-48.4%$0.00N/AN/A32
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+0.3%		N/A-23.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.37
-6.7%		N/A+805.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-9.5%		N/A-37.6%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.27
-16.8%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCSAW) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
BUY THIS: Claim a backdoor stake in SpaceX before June 12
SpaceX isn't public yet, but one trade available in a standard brokerage account could give you pre-IPO exposu...
Chaikin Analytics | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Elon Now Pays 15X More Than Your Bank
Elon Musk's new bank is offering 6% interest per year - that's 15 times the national average of 0.4% that most...
InvestorPlace | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel